T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Revolution Medicines
RVMD
$43.3B
| $257M | 0.03% |
5,865,962
+552,657
| +10% | +$27.9M |
|
377
GSK
GSK
$101B
| $256M | 0.03% |
7,566,922
+35,134
| +0.5% | +$1.26M |
|
378
Packaging Corp of America
PKG
$22.9B
| $255M | 0.03% |
1,134,398
-34,980
| -3% | -$8.09M |
|
379
NVR
NVR
$17B
| $255M | 0.03% |
31,133
-825
| -3% | -$7.51M |
|
380
Aon
AON
$75.7B
| $254M | 0.03% |
707,723
-8,273
| -1% | -$3.04M |
|
381
Upwork
UPWK
$1.08B
| $253M | 0.03% |
15,498,688
+5,289,493
| +52% | +$76.2M |
|
382
Roblox
RBLX
$27.1B
| $253M | 0.03% |
4,363,982
+871,027
| +25% | +$43.8M |
|
383
Webster Financial
WBS
$12.8B
| $252M | 0.03% |
4,555,537
-96,572
| -2% | -$5.3M |
|
384
New Oriental
EDU
$8.33B
| $250M | 0.03% |
3,894,541
+1,480,391
| +61% | +$94.9M |
|
385
Blackstone
BX
$112B
| $249M | 0.03% |
1,445,252
-1,429
| -0.1% | -$249K |
|
386
Edwards Lifesciences
EW
$53.4B
| $244M | 0.03% |
3,297,722
-244,061
| -7% | -$17.1M |
|
387
ICICI Bank
IBN
$106B
| $244M | 0.03% |
8,157,026
-586,637
| -7% | -$17.7M |
|
388
Owens Corning
OC
$12.3B
| $242M | 0.03% |
1,422,828
+414,770
| +41% | +$77.5M |
|
389
Vertiv
VRT
$111B
| $240M | 0.03% |
2,112,929
+77,859
| +4% | +$9.24M |
|
390
Dentsply Sirona
XRAY
$2.31B
| $238M | 0.03% |
12,549,242
+1,975,404
| +19% | +$41.8M |
|
|
TTAN
391
ServiceTitan Inc
TTAN
$8.94B
| $234M | 0.03% |
+2,274,102
| New | +$237M |
|
392
Ulta Beauty
ULTA
$22.2B
| $233M | 0.03% |
536,756
-28,404
| -5% | -$11M |
|
393
Realty Income
O
$59.6B
| $231M | 0.03% |
4,318,686
+110,694
| +3% | +$6.45M |
|
|
BNY
394
Bank of New York Mellon
BNY
$110B
| $229M | 0.03% |
2,980,918
-963,936
| -24% | -$74.5M |
|
395
Centene
CNC
$32.6B
| $228M | 0.03% |
3,770,426
+1,802,265
| +92% | +$112M |
|
396
Nucor
NUE
$61.8B
| $228M | 0.03% |
1,954,088
-381,278
| -16% | -$54.8M |
|
397
State Street
STT
$52.2B
| $227M | 0.03% |
2,309,130
+1,622,408
| +236% | +$154M |
|
398
Gaming and Leisure Properties
GLPI
$12.7B
| $226M | 0.03% |
4,688,546
-108,707
| -2% | -$5.44M |
|
399
TotalEnergies
TTE
$193B
| $225M | 0.03% |
4,133,617
-1,358,812
| -25% | -$82.6M |
|
400
Morningstar
MORN
$7.76B
| $225M | 0.03% |
668,889
-16,303
| -2% | -$5.57M |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.